Tudor Investment Corp
AGN

Tudor Investment Corp’s Allergan Inc AGN Stock Holding History

Tudor Investment Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,797
Closed -$1.45M – 1816
2014
Q4 		$1.45M Buy
6,797
+4,497
+196% +$894K 0.05% 216
2014
Q3 		$410K Sell
2,300
-600
-21% -$99.7K 0.01% 801
2014
Q2 		$491K Sell
2,900
-7,087
-71% -$1.1M 0.02% 547
2014
Q1 		$1.24M Buy
9,987
+6,387
+177% +$778K 0.05% 149
2013
Q4 		$400K Sell
3,600
-7,100
-66% -$678K 0.02% 715
2013
Q3 		$968K Sell
10,700
-3,700
-26% -$332K 0.04% 131
2013
Q2 		$1.21M Buy
+14,400
New +$1.49M 0.09% 107

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Tudor Investment Corp's AGN Position: Q1 2015 in Review

Tudor Investment Corp sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,797 shares — an estimated $1.45M sold.

Tudor Investment Corp first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.45M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Tudor Investment Corp reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Tudor Investment Corp sold 6,797 Allergan Inc shares in Q1 2015, an estimated $1.45M.
  • Tudor Investment Corp first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Tudor Investment Corp's Allergan Inc position peaked at $1.45M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Tudor Investment Corp's 13F filing for Q1 2015, filed 15 May 2015.